Prevention Strategies for Intentional Firearm Injuries
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve youth violence prevention programs by focusing on reducing firearm-related risks and preventing suicide among U.S. youth. Researchers will gather insights from teenagers at higher risk of firearm injuries to develop new strategies that enhance existing prevention efforts. The trial seeks participants aged 13-17 who have a history of violent injury or are referred by violence prevention programs.
As an unphased trial, this study offers participants the chance to contribute to groundbreaking strategies that could significantly enhance youth safety and well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this prevention strategy is safe?
Research shows that improving current prevention strategies can lower the risk of firearm injuries among young people. Although specific safety data for this trial is unavailable, it builds on well-established programs that have successfully reduced violence risks in the past. These programs have proven effective and are generally safe.
Since this trial enhances an existing strategy, its safety should align with the original program. This suggests it is likely safe for participants, as these programs have already been tested in real-world settings. The trial will add specific information about firearm risks, but this should not significantly alter safety concerns.
Prospective participants should know that these programs aim to create a safer environment by addressing important issues. This enhancement is not a new medical treatment, so there is no need to worry about medication side effects. Instead, the focus is on improving education and awareness strategies, which are generally safe and helpful.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to enhance existing prevention strategies for intentional firearm injuries by actively involving youth in the process. Unlike traditional approaches that might rely solely on expert opinions, this trial gathers insights directly from young people through interviews to identify specific risk and protective factors related to firearm injuries. This youth-driven approach ensures that the intervention is relevant and tailored to actual experiences and challenges faced by the community, potentially leading to more effective prevention strategies. This collaborative model, which integrates the voices of youth in developing the intervention, is a key innovation that sets it apart from standard methods.
What evidence suggests that enhancing an existing prevention strategy could be effective for reducing firearm-related risks among youth?
Research has shown that current programs to prevent youth violence successfully reduce aggression and similar behaviors. However, these programs often overlook specific firearm-related risks, crucial for preventing intentional gun injuries. This trial will explore enhancing an existing prevention strategy by incorporating firearm-specific elements. Studies have found that adding information about firearms to these programs can address this gap. By focusing on factors like gun accessibility and safe storage, these improved strategies might lower the risk of gun injuries among young people. Therefore, adding firearm-specific prevention strategies to existing programs could effectively address this important issue.24678
Who Is on the Research Team?
Kelly O'Connor
Principal Investigator
Virginia Commonwealth University
Are You a Good Fit for This Trial?
This trial is for English-speaking youth aged approximately 13-17 years who are at high risk for firearm-related injury, such as those with a history of violent injury or referrals from violence prevention programs. They must be able to agree to participate and have parental consent if under 18.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Development
Youth Participatory Action Research (YPAR) Advisory Board develops the focus group protocol and intervention manual
Intervention
Implementation of the SAFE Futures intervention to reduce risk factors associated with intentional firearm violence and suicide
Follow-up
Participants are monitored for changes in attitudes, norms, and behaviors related to firearm safety
What Are the Treatments Tested in This Trial?
Interventions
- Enhancing an Existing Prevention Strategy
Trial Overview
The study aims to enhance existing youth violence prevention strategies by focusing on reducing intentional firearm injuries among high-risk youth. It includes forming focus groups, establishing an advisory board of high-risk youths, and providing feedback sessions and training.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
The advisory board of 15 youth. The advisory board will assist in developing the focus group protocol for Phase 1 qualitative data collection. (Members of the YPAR are eligible to participate in both arms).
Interviews with youth (30 participants) to identify relevant firearm-specific risk and protective factors that will be used to develop the theory and intervention in collaboration with an advisory board of 15 youth. (Members of the YPAR are eligible to participate in both arms).
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator
Citations
Challenges, Successes, and the Future of Firearm Injury ...
Firearm injuries constitute a major US public health crisis that requires urgent attention. Fatality rates have increased 34.9% over the past decade.
Preventing Firearm Injury and Death
Explore data, research findings, and effective strategies to prevent firearm injuries and deaths. Access essential resources for support and ...
3.
publichealth.jhu.edu
publichealth.jhu.edu/center-for-gun-violence-solutions/our-work/the-public-health-approach-to-prevent-gun-violenceThe Public Health Approach to Prevent Gun Violence
Collecting and distributing reliable firearm data is essential to combating gun violence through a public health approach.
4.
ctv.veeva.com
ctv.veeva.com/study/enhancing-an-existing-prevention-strategy-to-reduce-intentional-firearm-injuries-among-high-risk-youEnhancing an Existing Prevention Strategy to Reduce ...
These programs have demonstrated positive effects on reducing aggression and related behaviors, firearm-specific risk factors were largely ...
5.
gih.org
gih.org/publication/building-an-evidence-base-for-gun-violence-prevention-research-and-data-needs/Building an Evidence-Base for Gun Violence Prevention
Experts have recommended a variety of improvements to existing data systems to address these deficiencies, including: enhancing the Behavioral Risk Factor ...
6.
trial.medpath.com
trial.medpath.com/clinical-trial/a3686bb9141dda78/nct07305467-prevention-strategy-reduce-firearm-injuries-youthEnhancing an Existing Prevention Strategy to Reduce ...
The study is designed to determine whether adding SAFE Futures to the Emerging Leaders program reduces risk factors associated with intentional ...
7.
cdc.gov
cdc.gov/firearm-violence/php/funded-research/current-three-year-awardees-rfa-ce-20-006.htmlRFA-CE-20-006: 3-year awards | Firearm Injury and Death ...
This project is designed to build the evidence base for interventions that promote safe behaviors related to youth firearm use and injury ...
Health Systems Interventions to Prevent Firearm Injuries
HEALTH SYSTEMS INTERVENTIONS TO PREVENT FIREARM INJURIES AND DEATH. PROCEEDINGS OF A WORKSHOP. Joe Alper, Melissa French, and Alexis Wojtowicz, Rapporteurs.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.